Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

James Burton to Recurrence

This is a "connection" page, showing publications James Burton has written about Recurrence.

 
Connection Strength
 
 
 
0.506
 
  1. Nordstrom EM, Biggins SW, Gralla J, Rosen HR, Everson GT, Burton JR. Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant. Exp Clin Transplant. 2015 Dec; 13(6):543-9.
    View in: PubMed
    Score: 0.104
  2. Burton JR, Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl. 2006 Nov; 12(11 Suppl 2):S38-47.
    View in: PubMed
    Score: 0.055
  3. Burton JR, Rosen HR. Treatment of HCV recurrence: do the pretransplantation rules apply? Liver Transpl. 2006 Jul; 12(7):1044-8.
    View in: PubMed
    Score: 0.054
  4. Burton JR, Rosen HR. Diagnosis and management of allograft failure. Clin Liver Dis. 2006 May; 10(2):407-35, x.
    View in: PubMed
    Score: 0.053
  5. Burton JR, Rosen HR. Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States. Clin Gastroenterol Hepatol. 2005 Jul; 3(7):700-4.
    View in: PubMed
    Score: 0.050
  6. Burton JR, Rosen HR. Retransplantation for hepatitis C: what do we really know? Liver Transpl. 2004 Dec; 10(12):1504-6.
    View in: PubMed
    Score: 0.048
  7. Burton JR, Sonnenberg A, Rosen HR. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Liver Transpl. 2004 Oct; 10(10 Suppl 2):S59-64.
    View in: PubMed
    Score: 0.048
  8. Verna EC, Saxena V, Burton JR, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study. Transplantation. 2015 Aug; 99(8):1644-51.
    View in: PubMed
    Score: 0.025
  9. Reiner JS, Lundergan CF, van den Brand M, Boland J, Thompson MA, Machecourt J, Py A, Pilcher GS, Fink CA, Burton JR, et al. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol. 1994 Nov 15; 24(6):1439-44.
    View in: PubMed
    Score: 0.024
  10. Biggins SW, Trotter J, Gralla J, Burton JR, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol. 2013 May; 58(5):969-76.
    View in: PubMed
    Score: 0.021
  11. Arjal RR, Burton JR, Villamil F, Rosen HR. Review article: the treatment of hepatitis C virus recurrence after liver transplantation. Aliment Pharmacol Ther. 2007 Jul 15; 26(2):127-40.
    View in: PubMed
    Score: 0.015
  12. Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, Smith JO, Burton JR, McCarthy WF, Califf RM, White HD, Weaver WD, Topol EJ, Ross AM. Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol. 1997 Jan; 29(1):35-42.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)